tiprankstipranks

BioLife Solutions price target raised to $30 from $28 at Lake Street

Lake Street analyst Thomas Flaten raised the firm’s price target on BioLife Solutions (BLFS) to $30 from $28 and keeps a Buy rating on the shares after the company reported Q3 results ahead of expectations and adjusted 2024 expectations to reflect recent divestitures and the improving financial profile.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue